Developing a needle-free sensor for continuous blood glucose monitoring
People with diabetes use glucose readings to guide food, activity and medication decisions. Current continuous monitors use sensors under the skin and may still require finger-stick checks. Sensor patches can also cause skin irritation.
Banting Labs is developing a non-invasive sensor for continuous blood glucose monitoring. It aims to give people with diabetes real-time readings without finger pricks, helping them track glucose changes and manage their condition.
What stands out about Banting Labs
Awarded a € 100,000 ACCIÓ Startup Capital grant in 2024 to support early development and business-model validation.
Closed a € 70,000 first investment round reported in March 2024, supporting prototype development and IP management.
Founding-team member and medical director Carlos Puig is a physician specializing in endocrinology and nutrition.
Selected for Biocat and CIMIT’s 2024 CRAASH Barcelona accelerator, with training in investment, patient engagement and pitching.
Based in the TecnoCampus incubator, as confirmed by the university and business park in its July 2024 announcement.
Won the 2022 Creatic award for best social-impact initiative through its founding glucose-monitoring project, originally called Hoop Diabetes.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.